It has been reported that breast cancer diagnosed in women under 40 years with triple negative or Her2-enriched tumors, is of poor prognosis and high metastasis incidence.38–41 It therefore appears that breast cancer in young women could constitute a biologically different entity. Here, ERBB2 is linked to breast cancer.